Angiogenic co‐operation of VEGF and stromal cell TP in endometrial carcinomas
暂无分享,去创建一个
A. Harris | K. Gatter | A. Giatromanolaki | M. Koukourakis | E. Sivridis | R. Bicknell | P. Anastasiadis | L. Georgiou
[1] A. Harris,et al. Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factors. , 2000, Cancer research.
[2] M Ancukiewicz,et al. Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions. , 2000, Cancer research.
[3] A. Harris,et al. ‘Invading edge vs. inner’ (edvin) patterns of vascularization: an interplay between angiogenic and vascular survival factors defines the clinical behaviour of non‐small cell lung cancer , 2000, The Journal of pathology.
[4] A. Giatromanolaki,et al. Cancer vascularization: implications in radiotherapy? , 2000, International journal of radiation oncology, biology, physics.
[5] L. Ellis,et al. Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases , 2000, Cancer.
[6] A. Harris,et al. Serum vascular endothelial growth factor load and interleukin-6 in cancer patients , 2000, British Journal of Cancer.
[7] K. O'Byrne,et al. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer , 2000, British Journal of Cancer.
[8] A. Giatromanolaki,et al. Angiogenesis, thymidine phosphorylase, and resistance of squamous cell head and neck cancer to cytotoxic and radiation therapy. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[9] H. Ito,et al. Thymidine phosphorylase expression is associated with both increase of intratumoral microvessels and decrease of apoptosis in human colorectal carcinomas. , 1999, Cancer research.
[10] N. Tsopanoglou,et al. On the Mechanism of Thrombin-induced Angiogenesis , 1999, The Journal of Biological Chemistry.
[11] K. Miyazaki,et al. Co-expression of vascular endothelial growth factor and thymidine phosphorylase in endometrial cancer. , 1999, Acta obstetricia et gynecologica Scandinavica.
[12] R. Weichselbaum,et al. Blockade of the Vascular Endothelial Growth Factor Stress Response Increases the Antitumor Effects of Ionizing Radiation , 1999 .
[13] A. Harris,et al. Thymidine phosphorylase expression in endometrial carcinomas , 1999, Clinical & Experimental Metastasis.
[14] M. Volm,et al. Inverse correlation between apoptotic (Fas ligand, caspase-3) and angiogenic factors (VEGF, microvessel density) in squamous cell lung carcinomas. , 1999, Anticancer research.
[15] D. Hanahan,et al. Tumor-derived expression of vascular endothelial growth factor is a critical factor in tumor expansion and vascular function. , 1999, Cancer research.
[16] H. Watanabe,et al. Histochemical study of vascular endothelial growth factor in squamous cell carcinoma of the esophagus. , 1999, Hepato-gastroenterology.
[17] K. Alitalo,et al. Vascular endothelial growth factor (VEGF)‐C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity , 1998, Journal of cellular physiology.
[18] Vishva Dixit,et al. Vascular Endothelial Growth Factor Regulates Endothelial Cell Survival through the Phosphatidylinositol 3′-Kinase/Akt Signal Transduction Pathway , 1998, The Journal of Biological Chemistry.
[19] A. Harris,et al. Neo-angiogenesis in locally advanced squamous cell head and neck cancer correlates with thymidine phosphorylase expression and p53 nuclear oncoprotein accumulation , 1998, Clinical & Experimental Metastasis.
[20] A. Harris,et al. Validation of anti‐vascular endothelial growth factor (anti‐VEGF) antibodies for immunohistochemical localization of VEGF in tissue sections: expression of VEGF in the human endometrium , 1998, The Journal of pathology.
[21] V. Dixit,et al. Vascular Endothelial Growth Factor Induces Expression of the Antiapoptotic Proteins Bcl-2 and A1 in Vascular Endothelial Cells* , 1998, The Journal of Biological Chemistry.
[22] K. O'Byrne,et al. Platelet-derived endothelial cell growth factor expression correlates with tumour angiogenesis and prognosis in non-small-cell lung cancer. , 1997, British Journal of Cancer.
[23] N. Ferrara,et al. The biology of vascular endothelial growth factor. , 1997, Endocrine reviews.
[24] M. Brizzi,et al. Activation of JAK2 in human vascular endothelial cells by granulocyte-macrophage colony-stimulating factor. , 1997, Blood.
[25] S. Akiba,et al. Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma. , 1996, Journal of the National Cancer Institute.
[26] A. Harris,et al. Platelet‐derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues: An immunohistochemical study , 1995, The Journal of pathology.
[27] H. Ishitsuka,et al. Expression of platelet‐derived endothelial cell growth factor/thymidine phosphorylase in human breast cancer , 1995, International journal of cancer.
[28] S. Fox,et al. Thymidine phosphorylase is angiogenic and promotes tumor growth. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[29] J. Pearson. Tumors of the Uterine Corpus and Gestational Trophoblastic Disease , 1993 .
[30] L. Copeland,et al. Stage I endometrial adenocarcinoma: treatment results in 835 patients. , 1983, American journal of obstetrics and gynecology.
[31] B. Fine,et al. VEGF, flt-1, and KDR/flk-1 as prognostic indicators in endometrial carcinoma. , 2000, Gynecologic oncology.
[32] A. Giatromanolaki,et al. Angiogenic interactions of vascular endothelial growth factor, of thymidine phosphorylase, and of p53 protein expression in locally advanced gastric cancer. , 2000, Oncology research.
[33] A. Giatromanolaki,et al. Intratumoral angiogenesis: a new prognostic indicator for stage I endometrial adenocarcinomas? , 1999, Oncology research.
[34] R. Weichselbaum,et al. Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. , 1999, Cancer research.
[35] Sandra R. Smith,et al. Growth factor effects on cells of the vascular wall: a survey. , 1993, Growth factors.
[36] Carcinoma of the endometrium. ACOG Technical Bulletin Number 162--December 1991. , 1993, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[37] H. Fox,et al. Biopsy pathology of the endometrium , 1989 .